Does new knowledge allow to improve the diagnosis of mental disorders: the problem of anti-NMDA receptor encephalitis?

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

A narrative review of research studies discusses the clinical features, differential diagnosis, and treatment of anti-NMDA receptor encephalitis. Special attention is given to the controversial aspects of the etiology and pathogenesis of this disorder. The need for further research into on the role of antibodies to NMDA receptors in the development of psychiatric disorders is emphasized.

About the authors

Alexander B. Shmukler

Moscow Research Institute of Psychaitry — Branch of the National Medical Research Center of Psychiatry and Addictions named after V.P. Serbsky

Author for correspondence.
Email: ashmukler@yandex.ru
ORCID iD: 0000-0002-7187-9361
SPIN-code: 4932-7980

MD, Dr. Sci. (Med.), Prof.

Russian Federation, Moscow

References

  1. Vitaliani R, Mason V, Ances B et al. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005;5(4):594–604. doi: 10.1002/ana.20614
  2. Dalmau J, Tuzun E, Wu H et al. Paraneoplastic anti-N-methyl-D-aspartate encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25–36. doi: 10.1002/ana.21050
  3. Zhao X, Teng Y, Ni J et al. Systematic review: Clinical characteristics of anti-N-methyl-D-aspartate receptor encephalitis. Front Hum Neurosci. 2023;17:1261638. doi: 10.3389/fnhum.2023.1261638
  4. Dalmau J, Armangué T, Planagumà J et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;11(18):1045–1057. doi: 10.1016/S1474-4422(19)30244-3
  5. Murashko AA. Anti-NMDA receptor encephalitis mimic psychiatric disorders. Social and Clinical Psychiatry. 2022;32(4):59–67. (In Russ.)
  6. Shmukler AB, Murashko AA. Practical recommendations for the diagnosis and treatment of patients with schizophrenia and other psychotic spectrum disorders with elevated levels of serum antibodies to NMDA receptors. Information letter. M.: National Research Center for Psychiatry and Narcology; 2022. 26 p. (In Russ.)
  7. Gillinder L, Warren N, Hartel G et al. EEG findings in NMDA encephalitis — A systematic review. Seizure. 2019;65:20–24. doi: 10.1016/j.seizure.2018.12.015
  8. Blackman G, Lim MF, Pollak Th et al. The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: A systematic review and meta-analysis of individual patient data. J Neurol. 2022;269:5302–5311. doi: 10.1007/s00415-022-11224-6
  9. Karyakina MV, Murashko AA. Cognitive impairment in patients with anti-NMDA receptor encephalitis. Social and Clinical Psychiatry. 2022;32(1):82–88. (In Russ.)
  10. McKeon GL, Robinson GA, Ryan AE et al. Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: A systematic review. J Clin Exper Neuropsychol. 2018;40(3):234–252. doi: 10.1080/13803395.2017.1329408
  11. Murashko AA. Mental disorders in autoimmune encephalitis. Social and Clinical Psychiatry. 2021;31(1):74–79. (In Russ.)
  12. Al-Diwani A, Handel A, Townsend L et al. The psychopathology of NMDAR-antibody encephalitis in adults: A systematic review and phenotypic analysis of individual patient data. Lancet. Psychiatry. 2019;6(3):235–246. doi: 0.1016/S2215-0366(19)30001-X
  13. Wang W, Zhang L, Chi X-S et al. Psychiatric symptoms of patients with anti-NMDA receptor encephalitis. Front Neurol. 2020;10:1330. doi: 10.3389/fneur.2019.01330
  14. Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J. Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurol. 2013;70(9):1133–1139. doi: 10.1001/jamaneurol.2013.3216
  15. Kawai H, Takaki M, Sakamoto S et al. Anti-NMDA-receptor antibody in initial diagnosis of mood disorder. Eur Neuropsychopharmacol. 2019;29(9):1041–1050. doi: 10.1016/j.euroneuro.2019.07.137
  16. Spektor VA. The role of antibodies to NMDA-receptors in the development of affective disorders. Social and Clinical Psychiatry. 2023;33(2):82–90. (In Russ.)
  17. Leonhard K. Aufteilung der endogenen Psychosen und ihre differenzierte Aetiologie. M.: Practicheskaya medicina; 2010. 456 р. (In Russ.)
  18. Komagamine T, Kanbayashi T, Suzuki K et al. “Atypical psychoses” and anti-NMDA receptor encephalitis: A review of literature in the mid-twentieth century. Psychiatry Clin Neurosci. 2022;76(2):62–63. doi: 10.1111/pcn.13317
  19. Mitsuda H. Klinisch-erbbiologische Untersuchung der Schizophrenie. Psychiatr Neurol Jap. 1942;46: 297–362. (In Japanese; quoted by Komagamine T et al., 2022.)
  20. Hatotani N, Ishida C, Yura R et al. Psychophysiological studies of atypical psychoses-endocrinological aspect of periodic psychoses. Folia Psychiatr Neurol Jap. 1962;16:248–292. (Quoted by Komagamine T et al., 2022.)
  21. Servén GE, Quintana BE, Ramírez MM et al. Cycloid psychosis as a psychiatric expression of anti-NMDAR encephalitis. A systematic review of case reports accomplished with the authors' cooperation. Brain Behav. 2021;11:e01980. doi: 10.1002/brb3.198
  22. Ehrenreich H. Autoantibodies against N-methyl-D-aspartate receptor 1 in health and disease. Curr Opin Neurol. 2018;31(3):306–312. doi: 10.1097/WCO.0000000000000546
  23. Gastaldi VD, Wilke JBH, Weidinger CA. Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: Analysis of 49 autoantibodies in over 7000 subjects. Brain Behav Immunity. 2023;108:135–147. doi: 10.1016/j.bbi.2022.10.016
  24. Shmukler AB, Ivashkina AA, Murashko AA. A case of anti-NMDA-receptor encephalitis presenting as febrile catatonia. Bulletin of Siberian Medicine. 2019;18(4):266–272. (In Russ.) doi: 10.20538/1682-0363-2019-4-266-272
  25. Kiryanova EM, Salnikova LI. Clinical case anti-NMDA receptor encephalitis. Social and Clinical Psychiatry. 2023;33(4):81–89. (In Russ.) doi: 10.34757/0869-4893.2023.33.4.010
  26. Davydovsky IV. The problem of causation in medicine (etiology). M.: Medgiz; 1962. 130 p. (In Russ.)
  27. Yu Y, Wu Y, Cao X et al. The clinical features and prognosis of anti-NMDAR encephalitis depends on blood brain barrier integrity. Mult Scler Relat Disord. 2021. Art. 102604. doi: 10.1016/j.msard.2020.102604
  28. Endres D, Meixensberger S, Dersch R et al. Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis. Transl Psychiatry. 2020;10(1):279. doi: 10.1038/s41398-020-00967-3
  29. Barkanova V, Shmukler AB. Disruption of the blood-brain barrier integrity and the development of movement disorders in patients with autoimmune diseases, characterized by the presence of psychopathological symptoms. Russian Psychiatric Journal. 2023;(3):91–103. (In Russ.)
  30. Ma Y, Wang J, Guo S et al., Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: A systematic review and meta-analysis. Front Immunol. 2023;13:1064007. doi: 10.3389/fimmu.2022.1064007
  31. Nabizadeh F, Balabandian M, Sodeifian F et al. Autoimmune encephalitis associated with COVID-19: A systematic review. Mult Scler Relat Disord. 2022;62:103795. doi: 10.1016/j.msard.2022.103795
  32. Swayne A, Warren N, Prain K et al. Analysing triggers for anti-NMDA-receptor encephalitis including herpes simplex virus encephalitis and ovarian teratoma: Results from the Queensland Autoimmune Encephalitis cohort. Intern Med J. 2022;52(11):1943–1949. doi: 10.1111/imj.15472
  33. Levite M. Glutamate receptor antibodies in neurological diseases: Anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: Epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. J Neural Transm (Vienna). 2014;121(8):1029–1075. doi: 10.1007/s00702-014-1193-3
  34. Gerosa M, Poletti B, Pregnolato F et al. Antiglutamate receptor antibodies and cognitive impairment in primary antiphospholipid syndrome and systemic lupus erythematosus. Front Immunol. 2016;7:5. doi: 10.3389/fimmu.2016.00005

Copyright (c) 2024 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies